Last reviewed · How we verify
NCT00800358
A Multi Centre, Open Label, Parallel Group, Randomized Controlled Trial to Compare the Safety and Efficacy of Oral Paricalcitol Versus Oral Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
NA trial testing Paricalitol in Hyperparathyroidism in 69 participants. Completed in 1 December 2009.
1 October 2009
Quick facts
| Lead sponsor | Penang Hospital, Malaysia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 69 |
| Start date | 1 November 2008 |
| Primary completion | 1 October 2009 |
| Estimated completion | 1 December 2009 |
| Sites | 11 locations across Malaysia |
Drugs / interventions tested
- Paricalitol — full drug profile →
- Calcitriol (CALCITRIOL) — full drug profile →
Conditions studied
- Hyperparathyroidism — all drugs for Hyperparathyroidism →
- Kidney Disease — all drugs for Kidney Disease →
Sponsor
Penang Hospital, Malaysia
Who can join
18 and older, any sex, with Hyperparathyroidism or Kidney Disease. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
More than 30% reduction in baseline iPTH concentration at 24 weeks of treatment with Paricalcitol or Calcitriol capsules.
Time frame: 24 weeks
Sponsor's own description
The purpose of this study is to determine whether oral paricalcitol is safer and more efficacious compared to oral calcitriol in the treatment of hyperparathyroidism in chronic kidney disease patients undergoing dialysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00800358
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperparathyroidism
Currently open trials in the same condition.
- NCT07415421 — Parathyroidectomy After Kidney Transplantation · NA · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
- NCT07010380 — Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder) · recruiting
- NCT06711874 — Abnormally High Parathyroid Hormone Levels Worsens Outcomes in Vitamin D Depleted Critical Care Patients · active not recruiting
- NCT06499142 — STP.168 Clinical Study Protocol Parakeet · NA · active not recruiting
Other Penang Hospital, Malaysia trials
Trials by the same sponsor.
- NCT06966804 — Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms · Phase 3 · recruiting
- NCT04818320 — Favipiravir in High-risk COVID-19 Patients · Phase 3 · completed
- NCT04503837 — Personalized Mobile Phone Video Recording to Improve Inhaler Techniques in Asthma Patients. · NA · unknown
- NCT03177031 — Clinical Performance and Safety Comparison of Stay Safe Link® With Stay Safe® in Patient on CAPD (CAPD-3) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00800358 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Penang Hospital, Malaysia
- Last refreshed: 4 December 2012
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00800358.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing